Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: George the Greek who wrote (554)	6/10/2003 2:12:19 PM
From: Icebrg	of 897

>> Since you say no one in their right mind would buy at $10, why have these institutional investors put money into this private placement?>> They have shorted the stock, taken delivery of the new stock from the private placement and pocketed the difference. An easy way to make some money. There has been no news to motivate the price rise. The stock is not worth more now than it was a month ago. Why should anyone take the risks investing in this company? >>How would this news change the instinct to short this stock, at the $12 level?>> Not at all. The stock will fall back again, regardless . >>Regarding the technology, VTAs: is this the same as anti-angiogenesis tech?>> Oxigene have their own version. They used to have BMY as a partner, but they returned the product rights.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next